Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Urinary stone evaluation in laboratory and clinical significance

1,522 views

Published on

Urinary Stones or Urolithiasis is a common, painful and destructive disease. It has a habit of recurrence. About half of Stones recur with in 5 to 7 years of first episode.
Stone disease tests are very useful to know cause of Stone formation. This is essential for focal prophylactic treatment to prevent recurrance.

  • Be the first to comment

Urinary stone evaluation in laboratory and clinical significance

  1. 1. Dr. Sanjeev Mehta MDDr. Sanjeev Mehta MD Ahmedabad, INDIAAhmedabad, INDIA www.urolab.net Metabolic Evaluation & Stone Analysis Practical implications
  2. 2. Role of laboratory • What lab can not tell you, you will not know. • What it tells you in error, you will not correct by using your instincts, your medical experience or your art. • Misdirected treatment : unreasonable expenses. • The Kidney Stone Handbook; Gail Savitz & co auth.
  3. 3. Stone : Supersaturation of Urine
  4. 4. Stone Promoting and Inhibiting Factors PROMOTORS INHIBITORS Calcium Inorganic : Magnesium Sodium Phosphorus Oxalate Citrate Urate Organic : Nephrocalcin Cystine Tomm-Horsfall Protein Low Urine Ph Urinary Prothrombin fragment. Tomm-Horsfall Protein Bacterial products
  5. 5. Evaluation of Stone Disease ROUTINE BLOOD AND URINE TESTS STONE ANALYSIS. 24 HRS URINE METABOLIC PROFILE New advances in Stone analysis, Blood and Urinary Chemical analysis can find out 90-95% cause.
  6. 6. Clinical usefulness 1.Identify treatable metabolic abnormality 2.Identify underlying medical disease that predisposes to stone formation. 3.Outline a treatment plan.
  7. 7. A. Routine Tests BLOOD low K, and HCO3- RTA High Uric acid - Uric acid diathesis High Calcium- pri hyperparathyroidism Low phosphorus- renal phosphorus leak. Parathyroid ; sos URINE pH > 7.5 – infection lithiasis pH < 5.5 – Uric acid lithiasis Sediments for crystalluria Urine culture Qualitative cystine
  8. 8. Renal Stone Analysis • Essential step in the examination and initial treatment of Urolithiasis. • Yields fundamental information about ; - Metabolic abnormality. - Presence of infection. - Possible artifacts. - Drug metabolism.
  9. 9. Technique Integrated analysis with Infra-red spectrometry Xenthene and Ca.oxalate Dihydrite
  10. 10. INTEGRETED ANALYSIS ; Mixed Stone
  11. 11. 11 Actually up to 65 different chemical compounds are found in urinary calculi.
  12. 12. Clinical significance of Stone analysis • Three categories : 1.Composition and hardness of Renal Stones. 2.Composition and its predictive value. 3.Composition and related metabolic abnormalities. Kourambas J, Aslan P, Teh CL, Mathias BJ, Preminger GM.J Endourol. 2001 Mar;15(2):181-6
  13. 13. Clinical Significance: Hardness pattern in Stone. • Useful in describing consistency in individual. • Formulation of treatment strategies. - Number of re-treatments. - Number of Shock waves. • Energy index (KV x number of shock waves). Ringdén I, Tiselius HG, Scand J Urol Nephrol. 2007;41(4):316-23
  14. 14. Hardness Factor of Stone Calcium Oxalate Dihydrate 1.0 Calcium Oxalate Monohydrate 1.3 Hydroxy-peptite 1.1 Brushite 2.2 Uric Acid/ Urate 1.0 Cystine 2.4 Carbonate Apatite 1.3 Struvite 1.0 Mixed Stone 1.0 * Ringden I, Scand J Urol Nephrol.2007;41(4):316-23
  15. 15. Clinical value : Calcium • Present in approximately 80% stones. • Combines with phosphate or oxalate or both. • Risk factors : hypercalciuria, Hyperoxaluria. hyperuricosuria. predominantly acid or alk urine. hypocitraturia. low urine volume.
  16. 16. Calcium Stones ….. Pure calcium Stones • More Acid urine • Low Urine volume • High Oxalate excretion Mixed Stone formers • pH is higher • High Calcium • High Calcium excretion • High recurrence rate * Schroeppel j Smith et all ; J Am Soc Nephrol 1997;8:568A
  17. 17. Calcium Stone….. Ca-oxalate Monohydrate • Hypo- megnesuria • Acidic Urine • Low Urine volume • Hardness + • Ca-ox Dihydrate • Hyper-calciuria • Alkaline Urine • Hypo-citraturia • Hardness ; less
  18. 18. Renal tubular acidosis Carbonate apattite • Consider RTA • Increases with amount • (5-39%) Brushite Stones • Consider RTA
  19. 19. Struvite Stone Magnesium Ammonium Phosphate • Mixed Stone : Infection. ‘Proteus’ • Strains of staphylococci, pseudomonas and kelbsiella. • Rarely; E.coli. • Urine Ph. Is < 7.5
  20. 20. Ammonium Urate • Calcium oxalate – containing calculi, may start hyperuricosuria. • Elders : associated with infection. • Children : May as result of hyperuricosuria, but No UTI
  21. 21. Brushite : Amm. Calcium Phosphate • Sizable stone burden. Increasing trend • High recurrence rate , 3 yrs • Familial tendency • Hypercalciurea and underlying metabolic abnormality. • Extreme Alkaline Urine. J Urol. Oct 2010; 184(4): 1367–1371.
  22. 22. Dahilite ( Carbonate apatite) • Phosphate stone • Infection in body. • May not accompanying sign of disease. • RTA • Disorder of phosphate metabolism. • Rare in pure form ( 2-3%).
  23. 23. Uric Acid URIC ACID • Hyperuricemia, hyperuricosuria. • Low Urine Ph. < 6.2 • Causes: - Gout. - Myeloproliferative dis. - Chemotherapy and Radiotherapy.
  24. 24. Cystine CYSTINE • Cysteinuria. • Autosomal recessive disorder. • Occurs predominantly in pure form. • XENTHENE Most frequent causes: - Xanthinuria. - Absence of Xanthene oxidase. • Genetic autosomal hereditary recessive enzyme disorder. • Trigger : Allopurinol Treating Gout.
  25. 25. Urine: Metabolic Evaluation 24 hrs Urine collections: multiple parameters Stone risk factors : Quantitation Volume and pH Calcium Oxalate Citrate Uric acid. Creatinine
  26. 26. Metabolic Evaluation: 24 hrs Urine • Dietary risk factors: Sodium, Potassium Magnesium Urinary analysts : phosphorus, sulphate, Urea Children : state sample Repeat 24 hrs Urine collection 4-6 weeks post interventi
  27. 27. GOLD STANDARD Supersaturation value. •High risk parameter can be monitored. Graphic presentation
  28. 28. Super-saturation : Gold standard….
  29. 29. Conclusion • Advancement in laboratory can now diagnose cause of stone formation uo tp 90% cases. • By appropriate Stone analysis and metabolic evaluation can effectively treat impact of Nephrolithiasis and prevent recurrence .
  30. 30. Conclusion: Significance • Advancement in laboratory can diagnise cause of Stone disease up to 90% • Impact mitigated by appropriate metabolic evaluation. • Identify risk factor. • Focused medical treatment • Significantly reduces recurrence • Social and financial burden. • Batter quality of life
  31. 31. Thank you ! For further details contact: sanjeev@urolab.net Phone: +91 79 40380380

×